mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.22 |
0.0003 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0004 |
mRNA |
shikonin |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.0005 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0007 |